Revolo Biotherapeutics

Revolo Biotherapeutics is a revolutionary biotherapeutics company with the mission of transforming the treatment of autoimmune and allergic diseases by resetting the immune system to achieve long-term, superior disease remission. Our two leading platform drug candidates, ‘1805 and ‘1104, can reset the immune system in just a single dose, in an unparalleled manner. They have demonstrated unique efficacy and safety in preclinical and human studies without any immunosuppressive effects. With our disease-agnostic approach, we are uniquely positioned as pioneers in developing treatments for a wide range of autoimmune and allergic conditions.On March 5, 2021, Immune Regulation Limited officially changed its name to Revolo Biotherapeutics.